MF
BMY icon

Magnetar Financial’s Bristol-Myers Squibb BMY Stock Holding History

Magnetar Financial’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-105,400
Closed -$762K – 1344
2021
Q4 		$762K Buy
+105,400
New +$6.18M 0.01% 870

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Magnetar Financial's BMY Position: Q1 2026 in Review

Magnetar Financial opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 32,473 shares worth $1.94M. The stake represents 0.02% of the portfolio and ranks #323 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in BMY as recently as Q3 2025.

Magnetar Financial first reported a position in BMY in Q3 2014 and has held it in 28 quarters since. The position peaked at $23.5M in Q3 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Magnetar Financial held 32,473 shares of Bristol-Myers Squibb worth $1.94M as of Q1 2026.
  • Bristol-Myers Squibb was a new Magnetar Financial position in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of Magnetar Financial's portfolio in Q1 2026, its #323 holding.
  • Magnetar Financial first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 28 quarters since.
  • Magnetar Financial's Bristol-Myers Squibb position peaked at $23.5M in Q3 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.